The most important financial indicators for the company Ameris Pharma Srl - Unique Identification Number 30289726:
sales in 2023 was
2.196.397
euro, registering a net profit of
87.418
euro and having an average number of
12
employees.
Firma isi desfasoara activitatea in domeniul Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate.
In the last year of activity, the sales decreased by -0.3%, from 2.210.610 euro in the year 2022, to 2.196.397 euro in 2023.
The Net Profit decreased by -11.719 euro, from 99.438 euro in 2022, to 87.418 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
558.959 euro in 2023 which includes Inventories of
339.523 euro, Receivables of
94.620 euro and cash availability of
124.816 euro.
The company's Equity was valued at
126.748 euro, while total Liabilities amounted to
442.184 euro.
Equity increased by 27.369 euro, from 99.681 euro in 2022, to 126.748 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Ameris Pharma Srl